COVID-19 Impact on Global Ibandronate Market Size, Status and Forecast 2020-2026

July 2020 | 93 pages | ID: C67CFEE4D4B3EN
QYResearch

Abstracts

This report focuses on the global Ibandronate status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ibandronate development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Roche
• Apotex
• Mylan
• Sun Pharmaceutical
• Dr Reddy's Laboratories
• Aurobindo Pharma
• MACLEODS

Market segment by Type, the product can be split into

• Oral
• Injection

Market segment by Application, split into

• Hospital
• Drug store

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Ibandronate status, future forecast, growth opportunity, key market and key players.
• To present the Ibandronate development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Ibandronate are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ibandronate Revenue
1.4 Market Analysis by Type
  1.4.1 Global Ibandronate Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Oral
  1.4.3 Injection
1.5 Market by Application
  1.5.1 Global Ibandronate Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Drug store
1.6 Coronavirus Disease 2019 (Covid-19): Ibandronate Industry Impact
  1.6.1 How the Covid-19 is Affecting the Ibandronate Industry
    1.6.1.1 Ibandronate Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Ibandronate Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Ibandronate Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Ibandronate Market Perspective (2015-2026)
2.2 Ibandronate Growth Trends by Regions
  2.2.1 Ibandronate Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Ibandronate Historic Market Share by Regions (2015-2020)
  2.2.3 Ibandronate Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Ibandronate Market Growth Strategy
  2.3.6 Primary Interviews with Key Ibandronate Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Ibandronate Players by Market Size
  3.1.1 Global Top Ibandronate Players by Revenue (2015-2020)
  3.1.2 Global Ibandronate Revenue Market Share by Players (2015-2020)
  3.1.3 Global Ibandronate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ibandronate Market Concentration Ratio
  3.2.1 Global Ibandronate Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Ibandronate Revenue in 2019
3.3 Ibandronate Key Players Head office and Area Served
3.4 Key Players Ibandronate Product Solution and Service
3.5 Date of Enter into Ibandronate Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Ibandronate Historic Market Size by Type (2015-2020)
4.2 Global Ibandronate Forecasted Market Size by Type (2021-2026)

5 IBANDRONATE BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Ibandronate Market Size by Application (2015-2020)
5.2 Global Ibandronate Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Ibandronate Market Size (2015-2020)
6.2 Ibandronate Key Players in North America (2019-2020)
6.3 North America Ibandronate Market Size by Type (2015-2020)
6.4 North America Ibandronate Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Ibandronate Market Size (2015-2020)
7.2 Ibandronate Key Players in Europe (2019-2020)
7.3 Europe Ibandronate Market Size by Type (2015-2020)
7.4 Europe Ibandronate Market Size by Application (2015-2020)

8 CHINA

8.1 China Ibandronate Market Size (2015-2020)
8.2 Ibandronate Key Players in China (2019-2020)
8.3 China Ibandronate Market Size by Type (2015-2020)
8.4 China Ibandronate Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Ibandronate Market Size (2015-2020)
9.2 Ibandronate Key Players in Japan (2019-2020)
9.3 Japan Ibandronate Market Size by Type (2015-2020)
9.4 Japan Ibandronate Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Ibandronate Market Size (2015-2020)
10.2 Ibandronate Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Ibandronate Market Size by Type (2015-2020)
10.4 Southeast Asia Ibandronate Market Size by Application (2015-2020)

11 INDIA

11.1 India Ibandronate Market Size (2015-2020)
11.2 Ibandronate Key Players in India (2019-2020)
11.3 India Ibandronate Market Size by Type (2015-2020)
11.4 India Ibandronate Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Ibandronate Market Size (2015-2020)
12.2 Ibandronate Key Players in Central & South America (2019-2020)
12.3 Central & South America Ibandronate Market Size by Type (2015-2020)
12.4 Central & South America Ibandronate Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Roche
  13.1.1 Roche Company Details
  13.1.2 Roche Business Overview and Its Total Revenue
  13.1.3 Roche Ibandronate Introduction
  13.1.4 Roche Revenue in Ibandronate Business (2015-2020))
  13.1.5 Roche Recent Development
13.2 Apotex
  13.2.1 Apotex Company Details
  13.2.2 Apotex Business Overview and Its Total Revenue
  13.2.3 Apotex Ibandronate Introduction
  13.2.4 Apotex Revenue in Ibandronate Business (2015-2020)
  13.2.5 Apotex Recent Development
13.3 Mylan
  13.3.1 Mylan Company Details
  13.3.2 Mylan Business Overview and Its Total Revenue
  13.3.3 Mylan Ibandronate Introduction
  13.3.4 Mylan Revenue in Ibandronate Business (2015-2020)
  13.3.5 Mylan Recent Development
13.4 Sun Pharmaceutical
  13.4.1 Sun Pharmaceutical Company Details
  13.4.2 Sun Pharmaceutical Business Overview and Its Total Revenue
  13.4.3 Sun Pharmaceutical Ibandronate Introduction
  13.4.4 Sun Pharmaceutical Revenue in Ibandronate Business (2015-2020)
  13.4.5 Sun Pharmaceutical Recent Development
13.5 Dr Reddy's Laboratories
  13.5.1 Dr Reddy's Laboratories Company Details
  13.5.2 Dr Reddy's Laboratories Business Overview and Its Total Revenue
  13.5.3 Dr Reddy's Laboratories Ibandronate Introduction
  13.5.4 Dr Reddy's Laboratories Revenue in Ibandronate Business (2015-2020)
  13.5.5 Dr Reddy's Laboratories Recent Development
13.6 Aurobindo Pharma
  13.6.1 Aurobindo Pharma Company Details
  13.6.2 Aurobindo Pharma Business Overview and Its Total Revenue
  13.6.3 Aurobindo Pharma Ibandronate Introduction
  13.6.4 Aurobindo Pharma Revenue in Ibandronate Business (2015-2020)
  13.6.5 Aurobindo Pharma Recent Development
13.7 MACLEODS
  13.7.1 MACLEODS Company Details
  13.7.2 MACLEODS Business Overview and Its Total Revenue
  13.7.3 MACLEODS Ibandronate Introduction
  13.7.4 MACLEODS Revenue in Ibandronate Business (2015-2020)
  13.7.5 MACLEODS Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Ibandronate Key Market Segments
Table 2. Key Players Covered: Ranking by Ibandronate Revenue
Table 3. Ranking of Global Top Ibandronate Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Ibandronate Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Injection
Table 7. COVID-19 Impact Global Market: (Four Ibandronate Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Ibandronate Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Ibandronate Players to Combat Covid-19 Impact
Table 12. Global Ibandronate Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Ibandronate Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Ibandronate Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Ibandronate Market Share by Regions (2015-2020)
Table 16. Global Ibandronate Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Ibandronate Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Ibandronate Market Growth Strategy
Table 22. Main Points Interviewed from Key Ibandronate Players
Table 23. Global Ibandronate Revenue by Players (2015-2020) (Million US$)
Table 24. Global Ibandronate Market Share by Players (2015-2020)
Table 25. Global Top Ibandronate Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ibandronate as of 2019)
Table 26. Global Ibandronate by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Ibandronate Product Solution and Service
Table 29. Date of Enter into Ibandronate Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Ibandronate Market Size by Type (2015-2020) (Million US$)
Table 32. Global Ibandronate Market Size Share by Type (2015-2020)
Table 33. Global Ibandronate Revenue Market Share by Type (2021-2026)
Table 34. Global Ibandronate Market Size Share by Application (2015-2020)
Table 35. Global Ibandronate Market Size by Application (2015-2020) (Million US$)
Table 36. Global Ibandronate Market Size Share by Application (2021-2026)
Table 37. North America Key Players Ibandronate Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Ibandronate Market Share (2019-2020)
Table 39. North America Ibandronate Market Size by Type (2015-2020) (Million US$)
Table 40. North America Ibandronate Market Share by Type (2015-2020)
Table 41. North America Ibandronate Market Size by Application (2015-2020) (Million US$)
Table 42. North America Ibandronate Market Share by Application (2015-2020)
Table 43. Europe Key Players Ibandronate Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Ibandronate Market Share (2019-2020)
Table 45. Europe Ibandronate Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Ibandronate Market Share by Type (2015-2020)
Table 47. Europe Ibandronate Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Ibandronate Market Share by Application (2015-2020)
Table 49. China Key Players Ibandronate Revenue (2019-2020) (Million US$)
Table 50. China Key Players Ibandronate Market Share (2019-2020)
Table 51. China Ibandronate Market Size by Type (2015-2020) (Million US$)
Table 52. China Ibandronate Market Share by Type (2015-2020)
Table 53. China Ibandronate Market Size by Application (2015-2020) (Million US$)
Table 54. China Ibandronate Market Share by Application (2015-2020)
Table 55. Japan Key Players Ibandronate Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Ibandronate Market Share (2019-2020)
Table 57. Japan Ibandronate Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Ibandronate Market Share by Type (2015-2020)
Table 59. Japan Ibandronate Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Ibandronate Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Ibandronate Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Ibandronate Market Share (2019-2020)
Table 63. Southeast Asia Ibandronate Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Ibandronate Market Share by Type (2015-2020)
Table 65. Southeast Asia Ibandronate Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Ibandronate Market Share by Application (2015-2020)
Table 67. India Key Players Ibandronate Revenue (2019-2020) (Million US$)
Table 68. India Key Players Ibandronate Market Share (2019-2020)
Table 69. India Ibandronate Market Size by Type (2015-2020) (Million US$)
Table 70. India Ibandronate Market Share by Type (2015-2020)
Table 71. India Ibandronate Market Size by Application (2015-2020) (Million US$)
Table 72. India Ibandronate Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Ibandronate Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Ibandronate Market Share (2019-2020)
Table 75. Central & South America Ibandronate Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Ibandronate Market Share by Type (2015-2020)
Table 77. Central & South America Ibandronate Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Ibandronate Market Share by Application (2015-2020)
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Product
Table 82. Roche Revenue in Ibandronate Business (2015-2020) (Million US$)
Table 83. Roche Recent Development
Table 84. Apotex Company Details
Table 85. Apotex Business Overview
Table 86. Apotex Product
Table 87. Apotex Revenue in Ibandronate Business (2015-2020) (Million US$)
Table 88. Apotex Recent Development
Table 89. Mylan Company Details
Table 90. Mylan Business Overview
Table 91. Mylan Product
Table 92. Mylan Revenue in Ibandronate Business (2015-2020) (Million US$)
Table 93. Mylan Recent Development
Table 94. Sun Pharmaceutical Company Details
Table 95. Sun Pharmaceutical Business Overview
Table 96. Sun Pharmaceutical Product
Table 97. Sun Pharmaceutical Revenue in Ibandronate Business (2015-2020) (Million US$)
Table 98. Sun Pharmaceutical Recent Development
Table 99. Dr Reddy's Laboratories Company Details
Table 100. Dr Reddy's Laboratories Business Overview
Table 101. Dr Reddy's Laboratories Product
Table 102. Dr Reddy's Laboratories Revenue in Ibandronate Business (2015-2020) (Million US$)
Table 103. Dr Reddy's Laboratories Recent Development
Table 104. Aurobindo Pharma Company Details
Table 105. Aurobindo Pharma Business Overview
Table 106. Aurobindo Pharma Product
Table 107. Aurobindo Pharma Revenue in Ibandronate Business (2015-2020) (Million US$)
Table 108. Aurobindo Pharma Recent Development
Table 109. MACLEODS Company Details
Table 110. MACLEODS Business Overview
Table 111. MACLEODS Product
Table 112. MACLEODS Revenue in Ibandronate Business (2015-2020) (Million US$)
Table 113. MACLEODS Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Ibandronate Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Ibandronate Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Drug store Case Studies
Figure 7. Ibandronate Report Years Considered
Figure 8. Global Ibandronate Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Ibandronate Market Share by Regions: 2020 VS 2026
Figure 10. Global Ibandronate Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Ibandronate Market Share by Players in 2019
Figure 13. Global Top Ibandronate Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ibandronate as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Ibandronate Revenue in 2019
Figure 15. North America Ibandronate Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Ibandronate Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Ibandronate Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Ibandronate Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Ibandronate Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Ibandronate Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Ibandronate Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Roche Revenue Growth Rate in Ibandronate Business (2015-2020)
Figure 24. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Apotex Revenue Growth Rate in Ibandronate Business (2015-2020)
Figure 26. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Mylan Revenue Growth Rate in Ibandronate Business (2015-2020)
Figure 28. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sun Pharmaceutical Revenue Growth Rate in Ibandronate Business (2015-2020)
Figure 30. Dr Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Dr Reddy's Laboratories Revenue Growth Rate in Ibandronate Business (2015-2020)
Figure 32. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Aurobindo Pharma Revenue Growth Rate in Ibandronate Business (2015-2020)
Figure 34. MACLEODS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. MACLEODS Revenue Growth Rate in Ibandronate Business (2015-2020)
Figure 36. Bottom-up and Top-down Approaches for This Report
Figure 37. Data Triangulation
Figure 38. Key Executives Interviewed